SEC Form 4 · accession 0001179110-18-004809
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Crouse
Director
Period of report
Mar 21, 2018
Accepted (ET)
Mar 23, 2018 · 4:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 21, 2018 | M | 7,500 | $18.30 | A | 60,633 | D | |
| Common StockF1 | Mar 21, 2018 | S | 7,500 | $32.26 | D | 53,133 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right-to-buy)F3,F2 | $18.30 | Mar 21, 2018 | M | 7,500 | D | — | May 29, 2018 | Common Stock | 7,500 | 0 | D |
Explanation of responses
- F1Represents the weighted average sales price of the shares sold ranging from a low of $31.83 to a high of $32.52 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F2This option vested in twelve equal installments beginning on June 29, 2008.
- F3Not applicable.